Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**plant sterols + fish oil** is a combination dietary supplement consisting of plant sterols (including beta-sitosterol, campesterol, stigmasterol) and fish oil usually standardized to omega-3 fatty acids (EPA and DHA). The principal mechanism of plant sterols is to **inhibit intestinal absorption of cholesterol** via competition for incorporation into micelles and upregulation of enterocyte ATP-binding cassette transporters; this results in reduced serum LDL-cholesterol. The omega-3 fatty acids in fish oil **reduce triglycerides** via inhibition of hepatic VLDL synthesis and enhanced clearance of triglyceride-rich particles. Supplementation with both components has shown a synergistic effect, lowering LDL cholesterol and triglycerides simultaneously, and benefiting cardiovascular risk factors in people with hypercholesterolemia or metabolic syndrome. The supplement may also exert ancillary effects on inflammatory markers and glucose metabolism by modifying lipid profiles and insulin resistance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on plant sterols + fish oil.